Martin Kåberg

Publications
Grants
CV
Public outreach and news

Articles

Article: INTERNATIONAL JOURNAL OF DRUG POLICY. 2024;128:104433
Changes in hepatitis C virus prevalence and incidence among people who inject drugs in the direct acting antiviral era
Gahrton C; Naver G; Warnqvist A; Dalgard O; Aleman S; Kaberg M
Article: LANCET GASTROENTEROLOGY & HEPATOLOGY. 2024;9(4):366-382
Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions
Marshall AD; Willing AR; Kairouz A; Cunningham EB; Wheeler A; O'Brien N; Perera V; Ward JW; Hiebert L; Degenhardt L; Hajarizadeh B; Colledge S; Hickman M; Jawad D; Lazarus JV; Matthews GV; Scheibe A; Vickerman P; Dore GJ; Grebely J
Article: JOURNAL OF HEPATOLOGY. 2024;80(2):232-242
Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territories.
Polaris Observatory Collaborators
Article: SUBSTANCE USE & MISUSE. 2023;58(12):1473-1482
Legal Minors Who Inject: Differences in Socio-Demographics and Treatment Needs Compared to Adults in a Swedish National Sample of People with Injecting Drug Use.
Turner R; Barrett D; Petersson F; Kåberg M
Article: LANCET GASTROENTEROLOGY & HEPATOLOGY. 2023;8(10):879-907
Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study
Razavi-Shearer DM; Gamkrelidze I; Pan CQ; Jia J; Berg T; Gray RT; Lim Y-S; Chen C-J; Ocama P; Desalegn H; Abbas Z; Abdallah AR; Aghemo A; Ahmadbekova S; Ahn SH; Aho I; Akarca US; Al Masri NM; Alalwan AM; Alavian SM; Al-Busafi SA; Aleman S; Alfaleh FZ; Alghamdi AS; Al-Hamoudi WK; Aljumah AA; Al-Naamani K; Al-Rifai A; AlSerkal YM; Altraif IH; Amarsanaa J; Anderson M; Andersson MI; Armstrong P; Asselah T; Athanasakis K; Baatarkhuu O; Ben-Ari Z; Bensalem A; Bessone F; Biondi MJ; Bizri ARN; Blach S; Braga WSM; Brandao-Mello CE; Brosgart CL; Brown KA; Jr RSB; Bruggmann P; Brunetto MR; Buti M; Cabezas J; Casanovas T; Chae C; Chan HLY; Cheinquer H; Chen P-J; Cheng KJG; Cheon M-E; Chien C-H; Choudhuri G; Christensen PB; Chuang W-L; Chulanov V; Garza LEC; Coffin CS; Contreras FA; Coppola N; Cornberg M; Cowie B; Cramp ME; Craxi A; Crespo J; Cui F; Cunningham CW; Dalgard O; De Knegt RJ; De Ledinghen V; Dore GJ; Drazilova S; Duberg A-S; Egeonu S; Elbadri M; El-Kassas M; El-Sayed MH; Estes C; Etzion O; Farag E; Ferradini L; Ferreira PRA; Flisiak R; Forns X; Frankova S; Fung J; Gane EJ; Garcia V; Garcia-Samaniego J; Gemilyan M; Genov J; Gheorghe LS; Gholam PM; Gish RG; Goleij P; Gottfredsson M; Grebely J; Gschwantler M; Guingane NA; Hajarizadeh B; Hamid SS; Hamoudi W; Harris AM; Hasan I; Hatzakis A; Hellard ME; Hercun J; Hernandez J; Hockickova I; Hsu Y-C; Hu C-C; Husa P; Janicko M; Janjua N; Jarcuska P; Jaroszewicz J; Jelev D; Jeruma A; Johannessen A; Kaberg M; Kaita KDE; Kaliaskarova KS; Kao J-H; Kelly-Hanku A; Khamis F; Khan AG; Kheir OO; Khoudri I; Kondili LA; Konysbekova A; Kristian P; Kwon JA; Lagging M; Laleman W; Lampertico P; Lavanchy D; Lazaro P; Lazarus JV; Lee AU; Lee M-H; Liakina V; Luksic B; Malekzadeh R; Malu AO; Marinho RT; Mendes-Correa MC; Merat S; Meshesha BR; Midgard H; Mohamed R; Mokhbat JE; Mooneyhan E; Moreno C; Mortgat L; Mullhaupt B; Musabaev E; Muyldermans G; Naveira MCM; Negro F; Nersesov AV; Van TTN; Ning Q; Njouom R; Ntagirabiri R; Nurmatov ZS; Oguche S; Omuemu CE; Ong JP; Opare-Sem OK; Ormeci N; Orrego M; Osiowy C; Papatheodoridis GV; Peck-Radosavljevic M; Pessoa MG; Pham TND; Phillips RO; Pimenov N; Pincay-Rodriguez LDR; Plaseska-Karanfilska D; Pop C; Poustchi H; Prabdial-Sing NN; Qureshi H; Ramji A; Rautiainen H; Razavi-Shearer K; Remak WM; Ribeiro S; Ridruejo E; Rios-Hincapie CY; Robalino MC; Roberts LR; Roberts SK; Rodriguez M; Roulot D; Rwegasha J; Ryder SD; Sadirova S; Saeed U; Safadi R; Sagalova O; Said SS; Salupere R; Sanai FM; Sanchez-Avila JF; Saraswat VA; Sargsyants N; Sarrazin C; Sarybayeva G; Schreter I; Seguin-Devaux C; Seto W-K; Shah SR; Sharara AI; Sheikh M; Shouval D; Sievert W; Simojoki K; Simonova MY; Sinn DH; Sonderup MW; Sonneveld MJ; Spearman CW; Sperl J; Stauber RE; Stedman CAM; Sypsa V; Tacke F; Tan S-S; Tanaka J; Tergast TL; Terrault NA; Thompson AJ; Thompson PJ; Tolmane I; Tomasiewicz K; Tsang T-Y; Uzochukwu BSC; Van Welzen B; Vanwolleghem T; Vince A; Voeller AS; Waheed Y; Waked I; Wallace J; Wang C; Weis N; Wong GL-H; Wong VW-S; Wu J-C; Yaghi CG; Yesmembetov K; Yip TC-F; Yosry A; Yu M-L; Yuen M-F; Yurdaydin C; Zeuzem S; Zuckerman E; Razavi HA
Article: BMC PUBLIC HEALTH. 2023;23(1):1608
A study protocol for a European, mixed methods, prospective, cohort study of the effectiveness of naloxone administration by community members, in reversing opioid overdose: NalPORS
Metrebian N; Carter B; Eide D; Mcdonald R; Neale J; Parkin S; Dascal T; Mackie C; Day E; Guterstam J; Horsburgh K; Kaberg M; Kelleher M; Smith J; Thiesen H; Strang J
Article: JOURNAL OF HEPATOLOGY. 2023;79(2):576-580
Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countries
Razavi HA; Buti M; Terrault NA; Zeuzem S; Yurdaydin C; Tanaka J; Aghemo A; Akarca US; Al Masri NM; Alalwan AM; Aleman S; Alghamdi AS; Alghamdi S; Al-Hamoudi WK; Aljumah AA; Altraif IH; Asselah T; Ben-Ari Z; Berg T; Biondi MJ; Blach S; Braga WSM; Brandao-Mello CE; Brunetto MR; Cabezas J; Cheinquer H; Chen P-J; Cheon M-E; Chuang W-L; Coffin CS; Coppola N; Craxi A; Crespo J; De Ledinghen V; Duberg A-S; Etzion O; Ferraz MLG; Ferreira PRA; Forns X; Foster GR; Gaeta GB; Gamkrelidze I; Garcia-Samaniego J; Gheorghe LS; Gholam PM; Gish RG; Glenn J; Hercun J; Hsu Y-C; Hu C-C; Huang J-F; Janjua N; Jia J; Kaberg M; Kaita KDE; Kamal H; Kao J-H; Kondili LA; Lagging M; Lazaro P; Lazarus JV; Lee M-H; Lim Y-S; Marotta PJ; Navas M-C; Naveira MCM; Orrego M; Osiowy C; Pan CQ; Pessoa MG; Raimondo G; Ramji A; Razavi-Shearer DM; Razavi-Shearer K; Rios-Hincapie CY; Rodriguez M; Rosenberg WMC; Roulot DM; Ryder SD; Safadi R; Sanai FM; Santantonio TA; Sarrazin C; Shouval D; Tacke F; Tergast TL; Villalobos-Salcedo JM; Voeller AS; Yang H-I; Yu M-L; Zuckerman E
Article: HARM REDUCTION JOURNAL. 2023;20(1):72
Real-world hepatitis C treatment outcomes and reinfections among people who inject drugs at a needle and syringe program in Stockholm, Sweden
Lindqvist K; Thorin Z; Kaberg M
Article: INTERNATIONAL JOURNAL OF DRUG POLICY. 2023;115:104021
Take-Home Naloxone and risk management from the perspective of people who survived an opioid overdose in Stockholm-An analysis informed by drug, set and setting
Holmen E; Hammarberg A; Kaberg M; Storbjork J
Article: SUBSTANCE ABUSE TREATMENT PREVENTION AND POLICY. 2023;18(1):24
Sweden's first Take-Home Naloxone program: participant characteristics, dose endpoints and predictors for overdose reversals
Holmen E; Warnqvist A; Kaberg M
Article: QUALITY OF LIFE RESEARCH. 2023;32(1):197-207
Quality-adjusted life years among people who inject drugs in a needle syringe program in Sweden
Kaberg M; Larsson S; Bergstrom J; Hammarberg A
Article: BMC PSYCHIATRY. 2022;22(1):770
Patterns of mortality risk among patients with substance use disorder: an opportunity for proactive patient safety?
Svensson J; Bergstroem J; Kaberg M; Becker P
Article: INTERNATIONAL JOURNAL OF DRUG POLICY. 2022;107:103787
A rapid assessment of take-home naloxone provision during COVID-19 in Europe
McDonald R; Eide D; Abel-Ollo K; Barnsdale L; Carter B; Clausen T; Day E; Fonseca F; Holmen E; Horsburgh K; Kelleher M; Kaberg M; Ladenhauf M; McAuley A; Metrebian N; Neale J; Parkin S; Ratcliffe K; Rintoul C; Smith J; Stifanoviciute V; Torrens M; Thiesen H; Strang J
Article: LANCET GASTROENTEROLOGY & HEPATOLOGY. 2022;7(5):396-415
Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
Blach S; Terrault NA; Tacke F; Gamkrelidze I; Craxi A; Tanaka J; Waked I; Dore GJ; Abbas Z; Abdallah AR; Abdulla M; Aghemo A; Aho I; Akarca US; Alalwan AM; Blome MA; Al-Busafi SA; Aleman S; Alghamdi AS; Al-Hamoudi WK; Aljumah AA; Al-Naamani K; Al Serkal YM; Altraif IH; Anand AC; Anderson M; Andersson MI; Athanasakis K; Baatarkhuu O; Bakieva SR; Ben-Ari Z; Bessone F; Biondi MJ; Bizri ARN; Mello CEB; Brigida K; Brown KA; Brown RSJ; Bruggmann P; Brunetto MR; Busschots D; Buti M; Butsashvili M; Cabezas J; Chae C; Ivanova VC; Chan HLY; Cheinquer H; Cheng KJ; Cheon ME; Chien CH; Chien RN; Choudhuri G; Christensen PB; Chuang WL; Chulanov V; Cisneros LE; Coco B; Contreras FA; Cornberg M; Cramp ME; Crespo J; Cui F; Cunningham CW; Abou LD; Dalgard O; Dao DY; De Ledinghen V; Derbala MF; Deuba K; Dhindsa K; Djauzi S; Drazilova S; Duberg AS; Elbadri M; El-Sayed MH; Esmat G; Estes C; Ezzat S; Farkkila MA; Ferradini L; Ferraz MLG; Ferreira PRA; Kanizaj TF; Flisiak R; Frankova S; Fung J; Gamkrelidze A; Gane EJ; Garcia V; Garcia-Samaniego J; Gemilyan M; Genov J; Gheorghe LS; Gholam PM; Null AG; Gottfredsson M; Gray RT; Grebely J; Gschwantler M; Hajarizadeh B; Hamid SS; Hamoudi W; Hatzakis A; Hellard ME; Himatt S; Hofer H; Hrstic I; Hunyady B; Husa P; Husic-Selimovic A; Jafri WSM; Janicko M; Janjua NZ; Jarcuska P; Jaroszewicz J; Jerkeman A; Jeruma A; Jia J; Jonasson JG; Kaberg M; Kaita KDE; Null KSK; Kao JH; Kasymov OT; Hanku AK; Khamis F; Khamis J; Khan AG; Khandu L; Khoudri I; Kielland KB; Kim DY; Kodjoh N; Kondili LA; Krajden M; Krarup HB; Kristian P; Kwon JA; Lagging M; Laleman W; Lao WC; Lavanchy D; Lazaro P; Lazarus JV; Lee AU; Lee MH; Li MKK; Liakina V; Lim YS; Love A; Luksic B; Machekera SM; Malu AO; Marinho RT; Maticic M; Mekonnen HD; Mendes-Correa MC; Mendez-Sanchez N; Merat S; Meshesha BR; Midgard H; Mills M; Mohamed R; Mooneyhan E; Moreno C; Muljono DH; Mullhaupt B; Musabaev E; Muyldermans G; Nartey YA; Naveira MCM; Negro F; Nersesov AV; Njouom R; Ntagirabiri R; Nurmatov ZS; Obekpa SA; Oguche S; Olafsson S; Ong JP; Opare-Sem OK; Orrego M; Ovrehus AL; Pan CQ; Papatheodoridis GV; Peck-Radosavljevic M; Pessoa MG; Phillips RO; Pimenov N; Plaseska-Karanfilska D; Prabdial-Sing NN; Puri P; Null HQ; Rahman A; Ramji A; Razavi-Shearer DM; Razavi-Shearer K; Ridruejo E; Rios-Hincapie CY; Rizvi SMS; Robaeys GKMM; Roberts LR; Roberts SK; Ryder SD; Sadirova S; Saeed U; Safadi R; Sagalova O; Said SS; Salupere R; Sanai FM; Sanchez-Avila JF; Saraswat VA; Sarrazin C; Sarybayeva G; Seguin-Devaux C; Sharara AI; Sheikh M; Shewaye AB; Sievert W; Simojoki K; Simonova MY; Sonderup MW; Spearman CW; Sperl J; Stauber RE; Stedman CAM; Su TH; Suleiman A; Sypsa V; Antabak NT; Tan SS; Tergast TL; Thurairajah PH; Tolmane I; Tomasiewicz K; Tsereteli M; Uzochukwu BSC; Van de Vijver DAMC; van Santen DK; Van Vlierberghe H; Van Welzen B; Vanwolleghem T; Velez-Moller P; Villamil FG; Vince A; Waheed Y; Weis N; Wong VWS; Yaghi CG; Yesmembetov K; Yosry A; Yuen MF; Yunihastuti E; Zeuzem S; Zuckerman E; Razavi HA
Article: EUROSURVEILLANCE. 2021;26(49):2002093
Univariable associations between a history of incarceration and HIV and HCV prevalence among people who inject drugs across 17 countries in Europe 2006 to 2020-is the precautionary principle applicable?
Wiessing L; Kalamara E; Stone J; Altan P; Van Baelen L; Fotiou A; Garcia D; Goulao J; Guarita B; Hope V; Jauffret-Roustide M; Jurgelaitiene L; Kaberg M; Kamarulzaman A; Lemsalu L; Kivite-Urtane A; Kolaric B; Montanari L; Rosinska M; Sava L; Horvath I; Seyler T; Sypsa V; Tarjan A; Yiasemi I; Zimmermann R; Ferri M; Dolan K; Uuskula A; Vickerman P
Article: LIVER INTERNATIONAL. 2021;41(9):2024-2031
Hepatitis C elimination in Sweden: Progress, challenges and opportunities for growth in the time of COVID-19
Blach S; Blome M; Duberg A-S; Jerkeman A; Kaberg M; Klasa P-E; Lagging M; Razavi-Shearer D; Razavi H; Aleman S
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2021;56(7):855-861
Absence of interferon-λ 4 enhances spontaneous clearance of acute hepatitis C virus genotypes 1-3 infection
Waldenstrom J; Kaberg M; Alanko Blome M; Widell A; Bjorkman P; Nilsson S; Hammarberg A; Weiland O; Nystrom K; Lagging M
Article: HARM REDUCTION JOURNAL. 2021;18(1):52
Health literacy and changes in pattern of drug use among participants at the Stockholm Needle Exchange Program during the COVID-19 pandemic
Lindqvist K; Wallmofeldt C; Holmen E; Hammarberg A; Kaberg M
Journal article: LANCET PUBLIC HEALTH. 2021;6(5):e309-e323
Homelessness, unstable housing, and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis
Arum C; Fraser H; Artenie AA; Bivegete S; Trickey A; Alary M; Astemborski J; Iversen J; Lim AG; MacGregor L; Morris M; Ong JJ; Platt L; Sack-Davis R; van Santen DK; Solomon SS; Sypsa V; Valencia J; Van den Boom W; Walker JG; Ward Z; Stone J; Vickerman P
Article: INTERNATIONAL JOURNAL OF DRUG POLICY. 2021;90:103059
A prospective cohort study of risk behaviours, retention and loss to follow-up over 5 years among women and men in a needle exchange program in Stockholm, Sweden
Karlsson N; Kaberg M; Berglund T; Hammarberg A; Widman L; Ekstrom AM
Article: PLOS ONE. 2021;16(6):e0253710
Mortality among amphetamine users with hepatitis C virus infection: A nationwide study
Gahrton C; Hakansson A; Kaberg M; Jerkeman A; Habel H; Dalgard O; Duberg A-S; Aleman S
Article: HARM REDUCTION JOURNAL. 2020;17(1):84
A qualitative study of facilitators and barriers to participate in a needle exchange program for women who inject drugs
Falk MV; Stromdahl S; Ekstrom AM; Kaberg M; Karlsson N; Dahlborn H; Hammarberg A
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2020;55(5):574-580
High risk of non-alcoholic liver disease mortality in patients with chronic hepatitis C with illicit substance use disorder
Kaberg M; Larsson SB; Jerkeman A; Nystedt A; Duberg A-S; Kovamees J; Ydreborg M; Aleman S; Busch K; Blome MA; Weiland O; Soderholm J
Article: INFECTIOUS DISEASES. 2020;52(5):336-346
Significant decrease in injection risk behaviours among participants in a needle exchange programme
Kaberg M; Karlsson N; Discacciati A; Widgren K; Weiland O; Ekstrom AM; Hammarberg A
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2019;54(3):319-327
Hepatitis C virus (HCV) related liver fibrosis in people who inject drugs (PWID) at the Stockholm Needle Exchange - evaluated with liver elasticity
Kaberg M; Edgren E; Hammarberg A; Weiland O
Article: JOURNAL OF VIRAL HEPATITIS. 2018;25(12):1452-1461
Incidence and spontaneous clearance of hepatitis C virus (HCV) in people who inject drugs at the Stockholm Needle Exchange-Importance for HCV elimination
Kaberg M; Naver G; Hammarberg A; Weiland O
Article: JOURNAL OF HEPATOLOGY. 2018;68(3):402-411
Model projections on the impact of HCV treatment in the prevention of HCV transmission among people who inject drugs in Europe
Fraser H; Martin NK; Brummer-Korvenkontio H; Carrieri P; Dalgard O; Dillon J; Goldberg D; Hutchinson S; Jauffret-Roustide M; Kaberg M; Matser AA; Maticic M; Midgard H; Mravcik V; Ovrehus A; Prins M; Reimer J; Robaeys G; Schulte B; van Santen DK; Zimmermann R; Vickerman P; Hickman M
Article: LANCET GASTROENTEROLOGY & HEPATOLOGY. 2018;3(2):125-133
Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe
Marshall AD; Cunningham EB; Nielsen S; Aghemo A; Alho H; Backmund M; Bruggmann P; Dalgard O; Seguin-Devaux C; Flisiak R; Foster GR; Gheorghe L; Goldberg D; Goulis I; Hickman M; Hoffmann P; Jancoriene L; Jarcuska P; Kaberg M; Kostrikis LG; Makara M; Maimets M; Marinho RT; Maticic M; Norris S; Olafsson S; Ovrehus A; Pawlotsky J-M; Pocock J; Robaeys G; Roncero C; Simonova M; Sperl J; Tait M; Tolmane I; Tomaselli S; van der Valk M; Vince A; Dore GJ; Lazarus JV; Grebely J
Article: INFECTIOUS DISEASES. 2017;49(10):728-736
Prevalence of hepatitis C and pre-testing awareness of hepatitis C status in 1500 consecutive PWID participants at the Stockholm needle exchange program
Kaberg M; Hammarberg A; Lidman C; Weiland O
Article: LANCET GASTROENTEROLOGY & HEPATOLOGY. 2017;2(5):325-336
Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study
Razavi H; Robbins S; Zeuzem S; Negro F; Buti M; Duberg A-S; Roudot-Thoraval F; Craxi A; Manns M; Marinho RT; Hunyady B; Colombo M; Aleman S; Antonov K; Arkkila P; Athanasakis K; Blach S; Blachier M; Blasco AJ; Calinas F; Calleja JL; Christensen PB; Cramp ME; Croes E; de Knegt RJ; de Ledinghen V; Delile J-M; Estes C; Falconer K; Farkkila M; Flisiak R; Frankova S; Gamkrelidze I; Garcia-Samaniego J; Genov J; Gerstoft J; Gheorghe L; Goldis A; Gountas I; Gregorcic S; Gschwantler M; Gunter J; Halota W; Harcouet L; Hezode C; Hoffmann P; Horvath G; Hrstic I; Jarcuska P; Jelev D; Jeruma A; Kaberg M; Kieran J; Kondili LA; Kotzev I; Krarup H; Kristian P; Lagging M; Laleman W; Lazaro P; Liakina V; Luksic B; Maimets M; Makara M; Mateva L; Maticic M; Mennini FS; Mitova R; Moreno C; Mossong J; Murphy K; Nde H; Nemecek V; Nonkovic D; Norris S; Oltman M; Ovrehus ALH; Papatheodoridis G; Pasini K; Razavi-Shearer D; Razavi-Shearer K; Reesink HW; Reic T; Rozentale B; Ryder SD; Salupere R; Sarmento-Castro R; Sarrazin C; Schmelzer JD; Schreter I; Seguin-Devaux C; Simojoki K; Simonova M; Smit PJ; Souliotis K; Speiciene D; Sperl J; Starkel P; Struck D; Sypsa V; Thornton L; Tolmane I; Tomasiewicz K; Valantinas J; Van Damme P; de Vijver DV; van der Meer AJ; van Santen D; Van Vlierberghe H; Vandijck D; Vella S; Videcnik-Zorman J; Vogel W; Weis N; Hatzakis A
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2015;50(2):233-244
The future disease burden of hepatitis C virus infection in Sweden and the impact of different treatment strategies
Duberg A-S; Blach S; Falconer K; Kaberg M; Razavi H; Aleman S
Article: JOURNAL OF VIRAL HEPATITIS. 2014;21:60-89
Strategies to manage hepatitis C virus (HCV) disease burden
Wedemeyer H; Duberg AS; Buti M; Rosenberg WM; Frankova S; Esmat G; Ormeci N; Van Vlierberghe H; Gschwantler M; Akarca U; Aleman S; Balik I; Berg T; Bihl F; Bilodeau M; Blasco AJ; Brandao Mello CE; Bruggmann P; Calinas F; Calleja JL; Cheinquer H; Christensen PB; Clausen M; Coelho HSM; Cornberg M; Cramp ME; Dore GJ; Doss W; El-Sayed MH; Ergor G; Estes C; Falconer K; Felix J; Ferraz MLG; Ferreira PR; Garcia-Samaniego J; Gerstoft J; Giria JA; Goncales FLJ; Guimaraes Pessoa M; Hezode C; Hindman SJ; Hofer H; Husa P; Idilman R; Kaberg M; Kaita KDE; Kautz A; Kaymakoglu S; Krajden M; Krarup H; Laleman W; Lavanchy D; Lazaro P; Marinho RT; Marotta P; Mauss S; Mendes Correa MC; Moreno C; Muellhaupt B; Myers RP; Nemecek V; Ovrehus ALH; Parkes J; Peltekian KM; Ramji A; Razavi H; Reis N; Roberts SK; Roudot-Thoraval F; Ryder SD; Sarmento-Castro R; Sarrazin C; Semela D; Sherman M; Shiha GE; Sperl J; Starkel P; Stauber RE; Thompson AJ; Urbanek P; Van Damme P; van Thiel I; Vandijck D; Vogel W; Waked I; Weis N; Wiegand J; Yosry A; Zekry A; Negro F; Sievert W; Gower E
Article: JOURNAL OF VIRAL HEPATITIS. 2014;21:34-59
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm
Razavi H; Waked I; Sarrazin C; Myers RP; Idilman R; Calinas F; Vogel W; Mendes Correa MC; Hezode C; Lazaro P; Akarca U; Aleman S; Balik I; Berg T; Bihl F; Bilodeau M; Blasco AJ; Brandao Mello CE; Bruggmann P; Buti M; Calleja JL; Cheinquer H; Christensen PB; Clausen M; Coelho HSM; Cramp ME; Dore GJ; Doss W; Duberg AS; El-Sayed MH; Ergor G; Esmat G; Falconer K; Felix J; Ferraz MLG; Ferreira PR; Frankova S; Garcia-Samaniego J; Gerstoft J; Giria JA; Goncales FLJ; Gower E; Gschwantler M; Guimaraes Pessoa M; Hindman SJ; Hofer H; Husa P; Kaberg M; Kaita KDE; Kautz A; Kaymakoglu S; Krajden M; Krarup H; Laleman W; Lavanchy D; Marinho RT; Marotta P; Mauss S; Moreno C; Murphy K; Negro F; Nemecek V; Ormeci N; Ovrehus ALH; Parkes J; Pasini K; Peltekian KM; Ramji A; Reis N; Roberts SK; Rosenberg WM; Roudot-Thoraval F; Ryder SD; Sarmento-Castro R; Semela D; Sherman M; Shiha GE; Sievert W; Sperl J; Starkel P; Stauber RE; Thompson AJ; Urbanek P; Van Damme P; van Thiel I; Van Vlierberghe H; Vandijck D; Wedemeyer H; Weis N; Wiegand J; Yosry A; Zekry A; Cornberg M; Muellhaupt B; Estes C
Article: JOURNAL OF VIRAL HEPATITIS. 2014;21:5-33
Historical epidemiology of hepatitis C virus (HCV) in selected countries
Bruggmann P; Berg T; Ovrehus ALH; Moreno C; Brandao Mello CE; Roudot-Thoraval F; Marinho RT; Sherman M; Ryder SD; Sperl J; Akarca U; Balik I; Bihl F; Bilodeau M; Blasco AJ; Buti M; Calinas F; Calleja JL; Cheinquer H; Christensen PB; Clausen M; Coelho HSM; Cornberg M; Cramp ME; Dore GJ; Doss W; Duberg AS; El-Sayed MH; Ergor G; Esmat G; Estes C; Falconer K; Felix J; Ferraz MLG; Ferreira PR; Frankova S; Garcia-Samaniego J; Gerstoft J; Giria JA; Goncales FLJ; Gower E; Gschwantler M; Guimaraes Pessoa M; Hezode C; Hofer H; Husa P; Idilman R; Kaberg M; Kaita KDE; Kautz A; Kaymakoglu S; Krajden M; Krarup H; Laleman W; Lavanchy D; Lazaro P; Marotta P; Mauss S; Mendes Correa MC; Muellhaupt B; Myers RP; Negro F; Nemecek V; Ormeci N; Parkes J; Peltekian KM; Ramji A; Razavi H; Reis N; Roberts SK; Rosenberg WM; Sarmento-Castro R; Sarrazin C; Semela D; Shiha GE; Sievert W; Starkel P; Stauber RE; Thompson AJ; Urbanek P; van Thiel I; Van Vlierberghe H; Vandijck D; Vogel W; Waked I; Wedemeyer H; Weis N; Wiegand J; Yosry A; Zekry A; Van Damme P; Aleman S; Hindman SJ
Article: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2009;41(10):727-734
Knowledge of status and assessment of personal health consequences with hepatitis C are not enough to change risk behaviour among injecting drug users in Stockholm County, Sweden
Norden L; Saxon L; Kaberg M; Kall K; Franck J; Lidman C
Article: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2009;41(9):679-684
Hepatitis C infection among injection drug users in Stockholm Sweden: Prevalence and gender
Lidman C; Norden L; Kaberg M; Kall K; Franck J; Aleman S; Birk M
Show more

All other publications

Review: LANCET GASTROENTEROLOGY & HEPATOLOGY. 2023;8(6):533-552
Incidence of HIV and hepatitis C virus among people who inject drugs, and associations with age and sex or gender: a global systematic review and meta-analysis
Artenie A; Stone J; Fraser H; Stewart D; Arum C; Lim AG; Trickey A; Ward Z; Abramovitz D; Alary M; Astemborski J; Bruneau J; Clipman SJ; Coffin CS; Croxford S; Debeck K; Emanuel E; Hayashi K; Hermez JG; Low-Beer D; Luhmann N; Macphail G; Maher L; Palmateer NE; Patel EU; Sacks-Davis R; Van Den Boom W; van Santen DK; Walker JG; Hickman M; Vicerman P
Conference publication: EUROPEAN PSYCHIATRY. 2022;65:S176-S177
Psychiatrist-led treatment of hepatitis C (HCV) at an opioid agonist treatment (OAT) clinic in Stockholm - enhancing the HCV treatment care cascade
Kaberg M; Klasa P-E; Nordin T
Review: LIVER INTERNATIONAL. 2020;40:61-66
Hepatitis C elimination - Macro-elimination
Kaberg M; Weiland O
Conference publication: JOURNAL OF HEPATOLOGY. 2020;73:S354-S355
Treatment of hepatitis C at the Stockholm needle syringe program - treatment success, reinfection rates and challenges for HCV elimination
Kaberg M; Lang A-M
Thesis / dissertation: 2019
Hepatitis C in people who inject drugs in the Stockholm needle exchange program : incidence, spontaneous clearance and change in risk behaviour
Kåberg, Martin
Meeting abstract: JOURNAL OF HEPATOLOGY. 2019;70(1):E498
Hepatitis C virus related liver fibrosis in people who inject drugs at the Stockholm Needle Exchange evaluated with liver elasticy
Kaberg M; Edgren E; Hammarberg A; Weiland O
Conference publication: HEPATOLOGY. 2019;70:366A
ELEVATED RISK FOR LIVER RELATED MORTALITY IN CHRONIC HEPATITIS C PATIENTS BOTH WITH OR WITHOUT ILLICIT SUBSTANCE USE DISORDER: A NATION-WIDE REGISTER STUDY
Soderholm J; Larsson SB; Jerkeman A; Nystedt A; Duberg A-S; Kovamees J; Ydreborg M; Aleman S; Busch K; Blome MA; Weiland OR; Kaberg M
Editorial comment: LANCET GASTROENTEROLOGY & HEPATOLOGY. 2018;3(11):731-732
HCV treatment for people with recent drug use: time for new measures of success?
Ovrehus A; Kaberg M
Conference publication: JOURNAL OF HEPATOLOGY. 2017;66(1):S95-S96
Restrictions for reimbursement of interferon-free direct-acting antiviral therapies for HCV infection in Europe
Marshall AD; Nielsen S; Cunningham EB; Aghemo A; Alho H; Backmund M; Bruggmann P; Dalgard O; Flisiak R; Foster G; Gheorghe L; Goldberg D; Goulis I; Hickman M; Hoffmann P; Jancoriene L; Jarcuska P; Kaberg M; Makara M; Maimets M; Marinho R; Maticic M; Norris S; Olafsson S; Ovrehus A; Pawlotsky J-M; Pocock J; Robaeys G; Roncero C; Simonova M; Sperl J; Tait M; Tolmane I; Tomaselli S; van der Valk M; Vince A; Dore GJ; Lazarus JV; Grebely J
Conference publication: HEPATOLOGY. 2014;60:1047A
The impact of different strategies to reduce the burden of chronic hepatitis C infection, using new direct acting antivirals in Sweden
Duberg A-S; Blach S; Falconer K; Kaberg M; Razavi H; Aleman S

Grants

Risks of injection drug use in a Swedish context: Prevention of harms in practice according to users, treatment staff, and societal actors
Swedish Research Council for Health Working Life and Welfare
1 November 2021 - 31 October 2024
Preventive interventions for reducing mortality and morbidity among people who inject drugs – effects and experiences of Take-home naloxone within a needle exchange program
Swedish Research Council for Health Working Life and Welfare
1 November 2021 - 31 October 2024

Employments

Affiliated to Research, Department of Global Public Health, Karolinska Institutet, 2024-2027

Degrees and Education

Degree Of Doctor Of Philosophy, Department of Medicine, Huddinge, Karolinska Institutet, 2019
University Medical Degree, Karolinska Institutet, 2002

Articles

All other publications

Grants

Employments

Degrees and Education

News from KI

Events from KI